Cerebrospinal-fluid ATP is inappropriate as a biomarker of disease severity and treatment response in MELAS

Publication date: Available online 24 December 2019Source: MitochondrionAuthor(s): Josef FinstererAbstractNone, letter

Source: Mitochondrion - December 26, 2019 Category: Biochemistry Source Type: research